A functional SNP of interferon-γ gene is important for interferon-α-induced and spontaneous recovery from hepatitis C virus infection

被引:95
作者
Huang, Ying
Yang, Huiying
Borg, Brian B.
Su, Xiaowen
Rhodes, Shannon L.
Yang, Kai
Tong, Xiaomei
Tang, George
Howell, Charles D.
Rosen, Hugo R.
Thio, Chloe L.
Thomas, David L.
Alter, Harvey J.
Sapp, Ronda K.
Liang, T. Jake [1 ]
机构
[1] NIH, Ctr Clin, Dept Transfus Med, Bethesda, MD 20892 USA
[2] NIDDKD, Liver Dis Branch, NIH, Bethesda, MD 20892 USA
[3] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA
[4] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[5] Univ Colorado, Hlth Sci Ctr, Div Gastroenterol Hepatol, Denver, CO 80262 USA
[6] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA
关键词
genetics; human study; cytokine; viral clearance; antiviral treatment;
D O I
10.1073/pnas.0609954104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cytokine polymorphisms are associated with disease outcome and interferon (IFN) treatment response in hepatitis C virus (HCV) infection. We genotyped eight SNPs spanning the entire IFN-gamma gene in two cohorts and assessed the association between those polymorphisms and treatment response or spontaneous viral clearance. The first cohort was composed of 284 chronically HCV-infected patients who had received IFN-alpha-based therapy and the second was 251 i.v. drug users who had either spontaneously cleared HCV or become chronically infected. A SNP variant located in the proximal IFN-gamma promoter region next to the binding motif of heat shock transcription factor (HSF), -764G, was significantly associated with sustained virological response [P = 0.04, odds ratio (OR) = 3.51 (confidence interval 1.0-12.5)]. The association was independently significant in multiple logistic regression (P = 0.04) along with race, viral titer, and genotype. This variant was also significantly associated with spontaneous recovery [P = 0.04, OR = 3.51 (1.0-12.5)] in the second cohort. Functional analyses show that the G allele confers a two- to three-fold higher promoter activity and stronger binding affinity to HSF1 than the C allele. Our study suggests that the IFN-gamma promoter SNP -764G/C is functionally important in determining viral clearance and treatment response in HCV-infected patients and may be used as a genetic marker to predict sustained virological response in HCV-infected patients.
引用
收藏
页码:985 / 990
页数:6
相关论文
共 35 条
[1]   Single nucleotide polymorphisms in the interferon-γ and interleukin-10 genes do not influence chronic hepatitis C severity or T-cell reactivity to hepatitis C virus [J].
Abbott, WGH ;
Rigopoulou, E ;
Haigh, P ;
Cooksley, H ;
Mullerova, I ;
Novelli, M ;
Winstanley, A ;
Williams, R ;
Naoumov, NV .
LIVER INTERNATIONAL, 2004, 24 (02) :90-97
[2]   Polymorphisms in tumour necrosis factor-α, transforming growth factor-β, interleukin-10, interleukin-6, interferon-γ, and outcome of hepatitis C virus infection [J].
Barrett, S ;
Collins, M ;
Kenny, C ;
Ryan, E ;
Keane, CO ;
Crowe, J .
JOURNAL OF MEDICAL VIROLOGY, 2003, 71 (02) :212-218
[3]   Role of cytokine gene polymorphism and hepatic transforming growth factor β1 expression in recurrent hepatitis C after liver transplantation [J].
Ben-Ari, Z ;
Pappo, O ;
Druzd, T ;
Sulkes, J ;
Klein, T ;
Samra, Z ;
Gadba, R ;
Tambur, AR ;
Tur-Kaspa, R ;
Mor, E .
CYTOKINE, 2004, 27 (01) :7-14
[4]   Polymorphisms of the human IFNG gene noncoding regions [J].
Bream, JH ;
Carrington, M ;
O'Toole, S ;
Dean, M ;
Gerrard, B ;
Shin, HD ;
Kosack, D ;
Modi, W ;
Young, HA ;
Smith, MW .
IMMUNOGENETICS, 2000, 51 (01) :50-58
[5]   Grading and staging the histopathological lesions of chronic hepatitis. The Knodell histology activity index and beyond [J].
Brunt, EM .
HEPATOLOGY, 2000, 31 (01) :241-246
[6]   Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins [J].
Choukhi, A ;
Ung, S ;
Wychowski, C ;
Dubuisson, J .
JOURNAL OF VIROLOGY, 1998, 72 (05) :3851-3858
[7]   NEGATIVE TRANSCRIPTIONAL REGULATION OF THE INTERFERON-GAMMA PROMOTER BY GLUCOCORTICOIDS AND DOMINANT-NEGATIVE MUTANTS OF C-JUN [J].
CIPPITELLI, M ;
SICA, A ;
VIGGIANO, V ;
YE, JP ;
GHOSH, P ;
BIRRER, MJ ;
YOUNG, HA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (21) :12548-12556
[8]   Polymorphisms in the interferon-γ gene at position+874 in patients with chronic hepatitis C treated with high-dose interferon-α and ribavirin [J].
Dai, CY ;
Chuang, WL ;
Chang, WY ;
Chen, SC ;
Lee, LP ;
Hsieh, MY ;
Hou, NJ ;
Lin, ZY ;
Hsieh, MY ;
Wang, LY ;
Yu, ML .
ANTIVIRAL RESEARCH, 2005, 67 (02) :93-97
[9]   Mechanism of action of interferon and ribavirin in treatment of hepatitis C [J].
Feld, JJ ;
Hoofnagle, JH .
NATURE, 2005, 436 (7053) :967-972
[10]   Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs [J].
Frese, M ;
Schwärzle, V ;
Barth, K ;
Krieger, N ;
Lohmann, V ;
Mihm, S ;
Haller, O ;
Bartenschlager, R .
HEPATOLOGY, 2002, 35 (03) :694-703